Divergent effects of Aβ1-42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo

Brain Research

Volumn 1062, Issue 1-2, 2005, Pages 120-126

  Szegedi, Viktor ^a   Juhász, Gábor ^a   Budai, Dénes ^a   Penke, Botond ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Alzheimer's disease; Hippocampus; Microiontophoresis; Single unit recording

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMYLOID BETA PROTEIN[1-42]; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; KAINIC ACID; LEUCYLPROLYLTYROSYLPHENYLALANYLASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID; NEUROPROTECTIVE AGENT; PENTAPEPTIDE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; IONTOPHORESIS; LONG TERM POTENTIATION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; HIPPOCAMPUS; PHYSIOLOGY; WISTAR RAT;

AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE;

EID: 27744527103     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.09.014     Document Type: Article

References (35)

1. B.J. Blanchard, A. Chen, L.M. Rozeboom, K.A. Stafford, P. Weigele, and V.M. Ingram Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule Proc. Natl. Acad. Sci. U. S. A. 101 2004 14326 14332
2. D. Budai Ultralow-noise headstage and main amplifiers for extracellular spike recording Acta Biol. Szeged. 48 2004 13 17
3. D. Budai, and Z. Molnár Novel carbon fiber microeletrodes for extracellular electrophysiology Acta Biol. Szeged. 45 2001 65 73
4. Z. Datki, R. Papp, D. Zadori, K. Soos, L. Fulop, A. Juhasz, G. Laskay, C. Hetenyi, E. Mihalik, M. Zarandi, and B. Penke In vitro model of neurotoxicity of Abeta 1-42 and neuroprotection by a pentapeptide: irreversible events during the first hour Neurobiol. Dis. 17 2004 507 515
5. C. Debray, D. Diabira, J.L. Gaiarsa, Y. Ben-Ari, and H. Gozlan Contributions of AMPA and GABA(A) receptors to the induction of NMDAR-dependent LTP in CA1 Neurosci. Lett. 238 1997 119 122
6. A. Freitas da Rocha, A. Pereira Jr., and F.A. Bezerra Coutinho N-methyl-d-aspartate channel and consciousness: from signal coincidence detection to quantum computing Prog. Neurobiol. 64 2001 555 573
7. M. Frerking, D. Schmitz, Q. Zhou, J. Johansen, and R.A. Nicoll Kainate receptors depress excitatory synaptic transmission at CA3-(CA1 synapses in the hippocampus via a direct presynaptic action J. Neurosci. 21 2001 2958 2966
8. T. Gallarda, and H. Loo Memantine (Ebixa): a new therapeutic strategy for the treatment of moderate to severe forms of Alzheimer's disease Encephale 30 2004 69 79
9. T.C. Gamblin, F. Chen, A. Zambrano, A. Abraha, S. Lagalwar, A.L. Guillozet, M. Lu, Y. Fu, F. Garcia-Sierra, N. LaPointe, R. Miller, R.W. Berry, L.I. Binder, and V.L. Cryns Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 100 2003 10032 10037
10. J. Hardy, and D. Allsop Amyloid deposition as the central event in the aetiology of Alzheimer's disease Trends Pharmacol. Sci. 12 1991 383 388
11. T. Harkany, J. Mulder, M. Sasvari, I. Abraham, C. Konya, M. Zarandi, B. Penke, P.G. Luiten, and C. Nyakas N-Methyl-d-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against beta-amyloid neurotoxicity Neurobiol. Dis. 6 1999 109 121
12. T. Harkany, I. Abraham, W. Timmerman, G. Laskay, B. Toth, M. Sasvari, C. Konya, J.B. Sebens, J. Korf, C. Nyakas, M. Zarandi, K. Soos, B. Penke, and P.G. Luiten beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis Eur. J. Neurosci. 12 2000 2735 2745
13. C. Hetenyi, Z. Szabo, E. Klement, Z. Datki, T. Kortvelyesi, M. Zarandi, and B. Penke Pentapeptide amides interfere with the aggregation of beta-amyloid peptide of Alzheimer's disease Biochem. Biophys. Res. Commun. 292 2002 931 936
14. I. Ito, and H. Sugiyama Roles of glutamate receptors in long-term potentiation at hippocampal mossy fiber synapses NeuroReport 2 1991 333 336
15. V. Jensen, K.M. Kaiser, T. Borchardt, G. Adelmann, A. Rozov, N. Burnashev, C. Brix, M. Frotscher, P. Andersen, O. Hvalby, B. Sakmann, P.H. Seeburg, and R. Sprengel A juvenile form of postsynaptic hippocampal long-term potentiation in mice deficient for the AMPA receptor subunit GluR-A J. Physiol. 553 2003 843 856
16. S.A. Johnson, and V.F. Simmon Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report J. Mol. Neurosci. 19 2002 197 200
17. W. Kakegawa, K. Tsuzuki, Y. Yoshida, K. Kameyama, and S. Ozawa Input- and subunit-specific AMPA receptor trafficking underlying long-term potentiation at hippocampal CA3 synapses Eur. J. Neurosci. 20 2004 101 110
18. I. Klyubin, D.M. Walsh, W.K. Cullen, J.V. Fadeeva, R. Anwyl, D.J. Selkoe, and M.J. Rowan Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo Eur. J. Neurosci. 19 2004 2839 2846
19. A. Kolleker, J.J. Zhu, B.J. Schupp, Y. Qin, V. Mack, T. Borchardt, G. Kohr, R. Malinow, P.H. Seeburg, and P. Osten Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors Neuron 40 2003 1199 1212
20. L. Li, A. Sengupta, N. Haque, I. Grundke-Iqbal, and K. Iqbal Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration FEBS Lett. 566 2004 261 269
21. J.J. Miguel-Hidalgo, X.A. Alvarez, R. Cacabelos, and G. Quack Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40) Brain Res. 958 2002 210 221
22. Z. Molnar, K. Soos, I. Lengyel, B. Penke, V. Szegedi, and D. Budai Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo NeuroReport 15 2004 1649 1652
23. W.E. Muller, E. Mutschler, and P. Riederer Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia Pharmacopsychiatry 28 1995 113 124
24. A. Rodriguez-Moreno, and J. Lerma Kainate receptor modulation of GABA release involves a metabotropic function Neuron 20 1998 1211 1218
25. E. Ruther, A. Glaser, S. Bleich, D. Degner, and J. Wiltfang A prospective PMS study to validate the sensitivity for change of the D-scale in advanced stages of dementia using the NMDA-antagonist memantine Pharmacopsychiatry 33 2000 103 108
26. D.J. Selkoe Translating cell biology into therapeutic advances in Alzheimer's disease Nature 399 1999 A23 A31
27. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
28. D.J. Selkoe Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases Nat. Cell Biol. 6 2004 1054 1061
29. A. Stephan, S. Laroche, and S. Davis Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits J. Neurosci. 21 2001 5703 5714
30. V. Szegedi, L. Fulop, T. Farkas, E. Rozsa, H. Robotka, Z. Kis, Z. Penke, S. Horvath, Z. Molnar, Z. Datki, K. Soos, J. Toldi, D. Budai, M. Zarandi, and B. Penke Pentapeptides derived from Abeta 1-42 protect neurons from the modulatory effect of Abeta fibrils-An in vitro and in vivo electrophysiological study Neurobiol. Dis. 18 2005 499 508
31. Q. Wang, D.M. Walsh, M.J. Rowan, D.J. Selkoe, and R. Anwyl Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5 J. Neurosci. 24 2004 3370 3378
32. J. Wu, R. Anwyl, and M.J. Rowan Beta-amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus NeuroReport 6 1995 2409 2413
33. P.J. Yao, M. Zhu, E.I. Pyun, A.I. Brooks, S. Therianos, V.E. Meyers, and P.D. Coleman Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease Neurobiol. Dis. 12 2003 97 109
34. C. Ye, D.M. Walsh, D.J. Selkoe, and D.M. Hartley Amyloid beta-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-d-aspartate (NMDA) versus non-NMDA receptor/channel activation Neurosci. Lett. 366 2004 320 325
35. J.M. Zhang, and G.Y. Hu Huperzine A, a nootropic alkaloid, inhibits N-methyl-d-aspartate-induced current in rat dissociated hippocampal neurons Neuroscience 105 2001 663 669